Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending January 5, 2007. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically detailing increases in their personal holdings of Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on share transaction details. The only financial figure disclosed is the transaction price of GBP 14.00 per Ordinary Share.
Material Changes
There are no material changes to the company's financial position or operations reported in this filing. The document details an increase in shareholdings for specific individuals following the re-investment of dividends paid on January 4, 2007.
Guidance, Outlook, and Risks
The filing contains no management commentary, guidance, outlook, risks, contingencies, or unusual items. It is a compliance notification under Disclosure Rules 3.1.4R(1)(a) and 3.1.4R(1)(b).
Important Facts for Investors
- Transaction Type: Increase in personal shareholdings via dividend re-investment.
- Share Price: GBP 14.00 per Ordinary Share.
- Dividend Date: January 4, 2007.
- Notified Parties: Mr J S Heslop, Mrs P A Heslop, Mr R Bondy, Mr D Learmouth, Dr D Pulman, Mrs C Pulman, Mr A Witty, and Mrs C Witty.
- Notification Date: January 5, 2007.